Ocugen Inc reports results for the quarter ended in June - Earnings Summary

Ocugen

08/08/2024 14:51

* Ocugen Inc  OCGN.OQ  reported a quarterly adjusted loss
of 4
cents​​ per share for the quarter ended in June, higher than the
same quarter last year, when the company reported EPS of -8
cents.  The mean expectation of three analysts for the quarter
was for a loss of 5 cents per share. Wall Street expected
results to range from -6 cents to -5 cents per share.
    * Revenue was $1.14 million​; analysts expected zero. 
    * Ocugen Inc's reported EPS for the quarter was a loss of 4
cents​.
    * The company reported a quarterly loss of $10.29 million.
    * Ocugen Inc shares had fallen by 23.9% this quarter and
gained 105.2% so far this year.

FORECAST CHANGES
    * The mean earnings estimate of analysts had risen by
about 20% in
the last three months.​ 
    * In the last 30 days, there have been no earnings estimate
revisions by analysts covering the company.

RECOMMENDATIONS
    * The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 3 "strong buy" or "buy," no
"hold" and no "sell" or "strong sell." 
    * The average consensus recommendation for the biotechnology
&
medical research peer group is also "buy"

Wall Street's median 12-month price target for Ocugen Inc is
$7.00 
This summary was machine generated from LSEG data August 8 at
01:51 p.m. UTC. ​All figures in US dollars unless otherwise
stated. (For questions concerning the data in this report,
contact Estimates.Support@lseg.com. For any other questions or
feedback, contact RefinitivNewsSupport@thomsonreuters.com) QUARTER ENDING    ESTIMATE       ACTUAL         BEAT, MET,
                                                 MISSED
 Jun. 30 2024      -0.05          -0.04          Beat
 Mar. 31 2024      -0.06          -0.05          Beat
 Dec. 31 2023      -0.06          -0.03          Beat
 Sep. 30 2023      -0.07          -0.06          Beat